SCHEMBL24460244

SCHEMBL24460244

CC(C)c1cnc(NC(=O)c2cc(Cl)ccc2O)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 5/20 0.57
CCNE1 P24864 6/20 0.56
CDK2 P24941 6/20 0.56
CDK5 Q00535 6/20 0.56
P2RX1 P51575 5/20 0.50
TMPRSS4 Q9NRS4 5/20 0.49
P2RX4 Q99571 2/20 0.49
P2RX7 Q99572 2/20 0.49
STAT3 P40763 1/20 0.48
CCNT1 O60563 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CDK1 P06493 1/20 0.47
CDK4 P11802 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNA2 P20248 1/20 0.47
CCND1 P24385 1/20 0.47
CDK7 P50613 1/20 0.47
CDK9 P50750 1/20 0.47
CCNH P51946 1/20 0.47
MNAT1 P51948 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30771747 1.00 KCNMA1 (0.57) KCNMA1CCNE1CDK2CDK5P2RX1
SCHEMBL5835944 0.89 CDK2 (0.57) KCNMA1CCNE1CDK2CDK5CCNT1
SCHEMBL13055666 0.88 KCNMA1 (0.57) KCNMA1P2RX1TMPRSS4P2RX4P2RX7
SCHEMBL5835649 0.86 CCNE1 (0.57) CCNE1CDK2CDK5CCNT1ALDH1A1
SCHEMBL5835868 0.85 KCNMA1 (0.61) KCNMA1CCNE1CDK2CDK5ALDH1A1
SCHEMBL5835711 0.84 CDK2 (0.55) CCNE1CDK2CDK5CCNT1ALDH1A1
SCHEMBL10114085 0.84 KCNMA1 (0.61) KCNMA1P2RX1TMPRSS4P2RX4P2RX7
SCHEMBL24460247 0.83 CDK2 (0.54) KCNMA1CCNE1CDK2CDK5STAT3
SCHEMBL30472740 0.83 KCNMA1 (0.64) KCNMA1P2RX1TMPRSS4P2RX4P2RX7
SCHEMBL5836737 0.83 KMT2A (0.61) CCNE1CDK2CDK5STAT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2024-01-04 US claimed
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2024-01-04 US disclosed
WO-2022109148-A1 SMALL MOLECULE INHIBITORS OF SARS-COV-2 INFECTIONS THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2022-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections ACE2, ACE, TMPRSS2 KCNMA1 3777/4885CCNE1 2462/4885CDK2 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.